BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fruit/legume fibre - Bifidobacterium lemurum |
👶
Combined Lycium babarum polysaccharides and C-phycocyanin increase gastric Bifidobacterium relative abundance and protect against gastric ulcer caused by aspirin in rats. Nutrition & metabolism (Nutr Metab (Lond) ) Vol: 18 Issue 1 Pages: 4 Pub: 2021 Jan 6 Epub: 2021 Jan 6 Authors Hsieh SY , Lian YZ , Lin IH , Yang YC , Tinkov AA , Skalny AV , Chao JC , Html Article Publication |
| fruit/legume fibre - Bifidobacterium lemurum |
👶
Alginate- and Gelatin-Coated Apple Pieces as Carriers for Bifidobacterium animalis subsp. lactis DSM 10140. Frontiers in microbiology (Front Microbiol ) Vol: 11 Issue Pages: 566596 Pub: 2020 Epub: 2020 Oct 16 Authors Campaniello D , Bevilacqua A , Speranza B , Sinigaglia M , Corbo MR , Html Article Publication |
| fruit/legume fibre - Bifidobacterium lemurum |
👶
Dietary Quercetin Increases Colonic Microbial Diversity and Attenuates Colitis Severity in <i>Citrobacter rodentium</i>-Infected Mice. Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1092 Pub: 2019 Epub: 2019 May 16 Authors Lin R , Piao M , Song Y , Html Article Publication |
| fruit/legume fibre - Bifidobacterium lemurum |
👶
Effects of Commercial Apple Varieties on Human Gut Microbiota Composition and Metabolic Output Using an In Vitro Colonic Model. Nutrients (Nutrients ) Vol: 9 Issue 6 Pages: Pub: 2017 May 24 Epub: 2017 May 24 Authors Koutsos A , Lima M , Conterno L , Gasperotti M , Bianchi M , Fava F , Vrhovsek U , Lovegrove JA , Tuohy KM , Html Article Publication |
| fruit/legume fibre - Bifidobacterium lemurum |
👶
Review article: dietary fibre-microbiota interactions. Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther ) Vol: 42 Issue 2 Pages: 158-79 Pub: 2015 Jul Epub: 2015 May 24 Authors Simpson HL , Campbell BJ , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
